FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2260888900> ?p ?o ?g. }

• W2260888900 abstract "Abstract GVHD (graft-vs-host disease) is one of the major complications after allogeneic hematopoietic stem cell transplantation leading to substantial morbidity and mortality. Several murine models are used to investigate this systemic inflammatory disease in vivo and to identify possible targets for clinical treatment. However, current well-established murine GVHD models have their clinical limitations as they are based on major histocompatibility mismatches and only lethal irradiation as conditioning. Development of new treatment options would be forwarded by the availability of a more clinically relevant murine model. To reflect the clinical situation of transplantation and GVHD, we established a new murine GVHD model which is based on Chemotherapy conditioning and MHC-matched bone marrow transplantation (BMT). In LP/J -> C57BL/6 mouse model, our chemotherapy transplantation protocol resulted in stable full donor chimerism and development of acute GVHD. C57BL/6 recipients were conditioned with a 7-day busulfan-cyclophosphamide Chemotherapy protocol. Mice received for 5 days 20 mg/kg/day busulfan intraperitoneally (i.p.) and the last three days additionally 100 mg/kg/day cyclophosphamide. After a two-day resting phase, recipients were transplanted with 1.5 x 107 bone marrow and 2 x 106 splenic T cells from LP/J donors. Recipients showed good engraftment with already 80 % engraftment in peripheral blood at day 15 after BMT. 90 % donor chimerism in peripheral blood and bone marrow could be shown already at day 30 after BMT. LP/J and C75BL/6 mice share the same haplotype (H2b) with only mismatches at different minor histocompatibility loci. As in clinical BMT, GVHD still arises after MHC-matched transplantation because of multiple minor mismatches. We could show in our LP -> C57BL/6 model typical features of acute GVHD. Allogeneic transplanted animals showed significant decreased survival compared to syngeneic transplanted animals (Figure 1A). GVHD animals exhibited GVHD-typical weight loss (Figure 1B) and a significant increased clinical GVHD index consisting of five clinical parameters: weight loss, posture, activity, fur and skin (Figure 1C). Our model showed a strong skin phenotype, especially between day 15 and 25 after BMT extensive scurf spread over the whole body combined with fur loss. Pronounced weight loss and highest clinical GVHD index were monitored between day 15 and 25, implicating this period as acute phase of GVHD. Histopathologic analysis of GVHD organs (large bowel, liver and skin) confirmed acute GVHD symptoms in our model as histopathological scores after Lerner (1974,Transplant Proc 6:367-371) were significantly increased in GVHD animals compared to BMT recipients without GVHD (Figure 1D). We next characterized systemic inflammation in our model by determining the number of circulating inflammatory cells in peripheral blood at different time points by flow cytometry. CD8+ T cells were significantly increased in GVHD animals in acute phase (day 15 after BMT), whereas CD4+ T cells were elevated in late phase (day 50-60 after BMT). These data suggests, that in our model two inflammatory phases occur, an early acute CD8-driven and a late CD4-driven phase. Finally, we could demonstrate GVHD-typical T cell infiltration in GHVD target organs in acute phase (Figure 2). In large and small bowel, liver and skin CD4 and CD8 infiltration was significantly elevated in GVHD animals, however, CD8 infiltration was more prominent. We conclude that CD8 T cells play a prominent role in acute phase of GVHD in our model. In summary, we could establish a novel chemotherapy based minor mismatch GVHD model which shows good engraftment, typical features of acute GVHD and systemic and target organ specific inflammation. Our murine GVHD model closely resembles the clinical situation of MHC-matched stem cell transplantation and may help to better understand pathogenic mechanisms in GVHD and develop new treatment options. Disclosures: No relevant conflicts of interest to declare." @default.
• W2260888900 created "2016-06-24" @default.
• W2260888900 creator A5002413830 @default.
• W2260888900 creator A5009561924 @default.
• W2260888900 creator A5026551198 @default.
• W2260888900 creator A5059991986 @default.
• W2260888900 creator A5060493724 @default.
• W2260888900 creator A5069131872 @default.
• W2260888900 creator A5069975808 @default.
• W2260888900 creator A5070954234 @default.
• W2260888900 creator A5083918957 @default.
• W2260888900 creator A5087206249 @default.
• W2260888900 date "2013-11-15" @default.
• W2260888900 modified "2023-10-02" @default.
• W2260888900 title "Close To Clinics: Acute Gvhd In a Novel Chemotherapy Based Minor Mismatch Transplantation Model" @default.
• W2260888900 doi "https://doi.org/10.1182/blood.v122.21.5420.5420" @default.
• W2260888900 hasPublicationYear "2013" @default.
• W2260888900 type Work @default.
• W2260888900 sameAs 2260888900 @default.
• W2260888900 citedByCount "0" @default.
• W2260888900 crossrefType "journal-article" @default.
• W2260888900 hasAuthorship W2260888900A5002413830 @default.
• W2260888900 hasAuthorship W2260888900A5009561924 @default.
• W2260888900 hasAuthorship W2260888900A5026551198 @default.
• W2260888900 hasAuthorship W2260888900A5059991986 @default.
• W2260888900 hasAuthorship W2260888900A5060493724 @default.
• W2260888900 hasAuthorship W2260888900A5069131872 @default.
• W2260888900 hasAuthorship W2260888900A5069975808 @default.
• W2260888900 hasAuthorship W2260888900A5070954234 @default.
• W2260888900 hasAuthorship W2260888900A5083918957 @default.
• W2260888900 hasAuthorship W2260888900A5087206249 @default.
• W2260888900 hasConcept C109159458 @default.
• W2260888900 hasConcept C126322002 @default.
• W2260888900 hasConcept C147483822 @default.
• W2260888900 hasConcept C188280979 @default.
• W2260888900 hasConcept C202965653 @default.
• W2260888900 hasConcept C203014093 @default.
• W2260888900 hasConcept C2776694085 @default.
• W2260888900 hasConcept C2776755627 @default.
• W2260888900 hasConcept C2777408962 @default.
• W2260888900 hasConcept C2778880498 @default.
• W2260888900 hasConcept C2779972918 @default.
• W2260888900 hasConcept C2780007613 @default.
• W2260888900 hasConcept C2780611847 @default.
• W2260888900 hasConcept C28328180 @default.
• W2260888900 hasConcept C2908554679 @default.
• W2260888900 hasConcept C2911091166 @default.
• W2260888900 hasConcept C2993713153 @default.
• W2260888900 hasConcept C54355233 @default.
• W2260888900 hasConcept C71924100 @default.
• W2260888900 hasConcept C86803240 @default.
• W2260888900 hasConceptScore W2260888900C109159458 @default.
• W2260888900 hasConceptScore W2260888900C126322002 @default.
• W2260888900 hasConceptScore W2260888900C147483822 @default.
• W2260888900 hasConceptScore W2260888900C188280979 @default.
• W2260888900 hasConceptScore W2260888900C202965653 @default.
• W2260888900 hasConceptScore W2260888900C203014093 @default.
• W2260888900 hasConceptScore W2260888900C2776694085 @default.
• W2260888900 hasConceptScore W2260888900C2776755627 @default.
• W2260888900 hasConceptScore W2260888900C2777408962 @default.
• W2260888900 hasConceptScore W2260888900C2778880498 @default.
• W2260888900 hasConceptScore W2260888900C2779972918 @default.
• W2260888900 hasConceptScore W2260888900C2780007613 @default.
• W2260888900 hasConceptScore W2260888900C2780611847 @default.
• W2260888900 hasConceptScore W2260888900C28328180 @default.
• W2260888900 hasConceptScore W2260888900C2908554679 @default.
• W2260888900 hasConceptScore W2260888900C2911091166 @default.
• W2260888900 hasConceptScore W2260888900C2993713153 @default.
• W2260888900 hasConceptScore W2260888900C54355233 @default.
• W2260888900 hasConceptScore W2260888900C71924100 @default.
• W2260888900 hasConceptScore W2260888900C86803240 @default.
• W2260888900 hasLocation W22608889001 @default.
• W2260888900 hasOpenAccess W2260888900 @default.
• W2260888900 hasPrimaryLocation W22608889001 @default.
• W2260888900 hasRelatedWork W1983909089 @default.
• W2260888900 hasRelatedWork W1985977074 @default.
• W2260888900 hasRelatedWork W202070293 @default.
• W2260888900 hasRelatedWork W2044911692 @default.
• W2260888900 hasRelatedWork W2069493411 @default.
• W2260888900 hasRelatedWork W2072587411 @default.
• W2260888900 hasRelatedWork W2111948390 @default.
• W2260888900 hasRelatedWork W2244712234 @default.
• W2260888900 hasRelatedWork W2384712087 @default.
• W2260888900 hasRelatedWork W2404716175 @default.
• W2260888900 hasRelatedWork W2406337831 @default.
• W2260888900 hasRelatedWork W2406692855 @default.
• W2260888900 hasRelatedWork W2407825650 @default.
• W2260888900 hasRelatedWork W2537827429 @default.
• W2260888900 hasRelatedWork W2561119192 @default.
• W2260888900 hasRelatedWork W2592448843 @default.
• W2260888900 hasRelatedWork W2740817558 @default.
• W2260888900 hasRelatedWork W29336819 @default.
• W2260888900 hasRelatedWork W2979902603 @default.
• W2260888900 hasRelatedWork W3106575506 @default.
• W2260888900 isParatext "false" @default.
• W2260888900 isRetracted "false" @default.
• W2260888900 magId "2260888900" @default.
• W2260888900 workType "article" @default.